{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:32:50Z","timestamp":1793201570402,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,30]],"date-time":"2027-07-30T00:00:00Z","timestamp":1816905600000},"content-version":"am","delay-in-days":332,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008935","name":"Center of Excellence in Regulatory Science and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS113828"],"award-info":[{"award-number":["R01NS113828"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.msard.2026.107399","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:36:33Z","timestamp":1784561793000},"page":"107399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["OCT-defined optic atrophy thresholds are associated with blunted optic nerve swelling in recurrent optic neuritis"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9549-6648","authenticated-orcid":false,"given":"Stephanie B.","family":"Syc-Mazurek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delaney","family":"Liskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deena A.","family":"Tajfirouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Chodnicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriyar","family":"Majidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Duvigneaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Demortiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Stolowy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Kunchok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry P.","family":"Frohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Stiebel-Kalish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Zlatkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanyatuth","family":"Padungkiatsagul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Ayzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Audoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda D.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Marignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Froment","family":"Tilikete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias S.","family":"Sotirchos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Pittock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin P.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3644-7528","authenticated-orcid":false,"given":"John J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2026.107399_bib0037","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/WCO.0000000000001340","article-title":"Optical coherence tomography: implications for neurology","volume":"38","author":"Al-Ani","year":"2025","journal-title":"Curr. Opin. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2026.107399_bib0027","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1177\/1352458512439237","article-title":"Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography","volume":"18","author":"Albrecht","year":"2012","journal-title":"Mult. Scler."},{"issue":"12","key":"10.1016\/j.msard.2026.107399_bib0022","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1038\/s41433-024-03152-8","article-title":"Infectious optic neuropathy (ION), how to recognise it and manage it","volume":"38","author":"Ambika","year":"2024","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.msard.2026.107399_bib0030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/jamaneurol.2019.3283","article-title":"Using Acute optic neuritis trials to assess neuroprotective and remyelinating therapies in multiple sclerosis","volume":"77","author":"Andorra","year":"2020","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.msard.2026.107399_bib0031","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1212\/WNL.0000000000012125","article-title":"APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies","volume":"97","author":"Aytulun","year":"2021","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2026.107399_bib0001","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.msard.2026.107399_bib0042","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The optic neuritis study group","volume":"326","author":"Beck","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.msard.2026.107399_bib0014","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1474-4422(22)00187-9","article-title":"Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment","volume":"22","author":"Bennett","year":"2023","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.msard.2026.107399_bib0004","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00415-017-8615-8","article-title":"Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France","volume":"264","author":"Biotti","year":"2017","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2026.107399_bib0012","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1474-4422(22)00173-9","article-title":"Imaging of the optic nerve: technological advances and future prospects","volume":"21","author":"Biousse","year":"2022","journal-title":"Lancet Neurol."},{"issue":"13","key":"10.1016\/j.msard.2026.107399_bib0021","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S1474-4422(16)30237-X","article-title":"Diagnosis and clinical features of common optic neuropathies","volume":"15","author":"Biousse","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107399_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2025.578715","article-title":"Structural and functional biomarkers of visual dysfunction in MOG antibody-positive optic neuritis: a scoping review","volume":"408","author":"Chan","year":"2025","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107399_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104237","article-title":"Details and outcomes of a large cohort of MOG-IgG associated optic neuritis","volume":"68","author":"Chen","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107399_bib0006","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome","volume":"195","author":"Chen","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.msard.2026.107399_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103525","article-title":"OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and multiple sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS","volume":"58","author":"Chen","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2026.107399_bib0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/WCO.0000000000000766","article-title":"Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis","volume":"33","author":"Chen","year":"2020","journal-title":"Curr. Opin. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2026.107399_bib0025","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography","volume":"59","author":"Costello","year":"2006","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2026.107399_bib0032","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/WNO.0000000000002204","article-title":"Optic disc cupping in neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis and its relationship with optical coherence tomography parameters: a multicenter study","volume":"45","author":"Estrela","year":"2025","journal-title":"J. Neuroophthalmol."},{"issue":"3","key":"10.1016\/j.msard.2026.107399_bib0019","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.24351","article-title":"Dynamics of retinal injury after acute optic neuritis","volume":"77","author":"Gabilondo","year":"2015","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2026.107399_bib0013","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1055\/s-0039-1700528","article-title":"Optical coherence tomography in multiple sclerosis","volume":"39","author":"Graves","year":"2019","journal-title":"Semin. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2026.107399_bib0018","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/brain\/awq146","article-title":"A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials","volume":"133","author":"Henderson","year":"2010","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.msard.2026.107399_bib0039","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1038\/s41433-024-03108-y","article-title":"MOG antibody-associated optic neuritis","volume":"38","author":"Jeyakumar","year":"2024","journal-title":"Eye (L)"},{"issue":"4","key":"10.1016\/j.msard.2026.107399_bib0035","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/WNO.0000000000001717","article-title":"Normative data and conversion equation for spectral-domain optical coherence tomography in an international healthy control cohort","volume":"42","author":"Kenney","year":"2022","journal-title":"J. Neuroophthalmol."},{"issue":"1\u00ad2","key":"10.1016\/j.msard.2026.107399_bib0016","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2011.05.039","article-title":"One and three month changes in the peripapillary retinal nerve fiber layer in acute optic neuritis: relation to baseline vision and MRI","volume":"308","author":"Kupersmith","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.msard.2026.107399_bib0044","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jamaneurol.2024.2811","article-title":"Time to treat first acute attack of myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"81","author":"Kwon","year":"2024","journal-title":"JAMA Neurol."},{"issue":"9450","key":"10.1016\/j.msard.2026.107399_bib0008","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0140-6736(04)17517-X","article-title":"The eye in neurological disease","volume":"364","author":"Miller","year":"2004","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.msard.2026.107399_bib0002","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.msard.2026.107399_bib0023","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ana.26440","article-title":"Longitudinal retinal changes in MOGAD","volume":"92","author":"Oertel","year":"2022","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2026.107399_bib0028","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001068","article-title":"Retinal optical coherence tomography in neuromyelitis optica","volume":"8","author":"Oertel","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.msard.2026.107399_bib0041","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200531","article-title":"OCT-based differentiation of first acute optic neuritis: an international study of 111 patients with NMOSD and MOGAD","volume":"13","author":"Pakeerathan","year":"2026","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.msard.2026.107399_bib0026","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","article-title":"Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis","volume":"16","author":"Petzold","year":"2017","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.msard.2026.107399_bib0015","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1474-4422(10)70168-X","article-title":"Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis","volume":"9","author":"Petzold","year":"2010","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.msard.2026.107399_bib0020","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1474-4422(22)00200-9","article-title":"Diagnosis and classification of optic neuritis","volume":"21","author":"Petzold","year":"2022","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.msard.2026.107399_bib0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jnnp-2022-330360","article-title":"Time to steroids impacts visual outcome of optic neuritis in MOGAD","volume":"94","author":"Rode","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.msard.2026.107399_bib0029","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/WNO.0000000000002124","article-title":"Myelin oligodendrocyte glycoprotein antibody disease optic neuritis: a structure-function paradox?","volume":"44","author":"Ross","year":"2024","journal-title":"J. Neuroophthalmol."},{"issue":"10","key":"10.1016\/j.msard.2026.107399_bib0038","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1474-4422(25)00275-3","article-title":"The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis","volume":"24","author":"Saidha","year":"2025","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.msard.2026.107399_bib0034","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1352458514538110","article-title":"Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria","volume":"21","author":"Schippling","year":"2015","journal-title":"Mult. Scler."},{"issue":"Pt 2","key":"10.1016\/j.msard.2026.107399_bib0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awr264","article-title":"Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis","volume":"135","author":"Syc","year":"2012","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.msard.2026.107399_bib0011","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/1352458510371640","article-title":"Reproducibility of high-resolution optical coherence tomography in multiple sclerosis","volume":"16","author":"Syc","year":"2010","journal-title":"Mult. Scler."},{"issue":"12","key":"10.1016\/j.msard.2026.107399_bib0009","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis. Experience of the optic neuritis treatment trial. optic neuritis study group","volume":"109","year":"1991","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.msard.2026.107399_bib0024","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.msard.2026.107399_bib0036","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200291","article-title":"Diagnostic value of inter-eye difference metrics on oct for myelin oligodendrocyte glycoprotein antibody-associated optic neuritis","volume":"11","author":"Volpe","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.msard.2026.107399_bib0003","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2026.107399_bib0033","doi-asserted-by":"crossref","first-page":"e527","DOI":"10.1212\/WNL.0000000000006873","article-title":"Optical coherence tomography is highly sensitive in detecting prior optic neuritis","volume":"92","author":"Xu","year":"2019","journal-title":"Neurology."},{"issue":"10","key":"10.1016\/j.msard.2026.107399_bib0007","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/bjophthalmol-2017-311177","article-title":"Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients","volume":"102","author":"Zhao","year":"2018","journal-title":"Br. J. Ophthalmol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826004347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826004347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:52:51Z","timestamp":1787921571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826004347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":45,"alternative-id":["S2211034826004347"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107399","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OCT-defined optic atrophy thresholds are associated with blunted optic nerve swelling in recurrent optic neuritis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107399"}}